Noriaki Kurata

Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein.

Eiichi Fuse, Hiromi Tanii, Noriaki Kurata et al. · PubMed · 1998 · 203 citations

Molecular Pharmacology, Alpha1-acid Glycoprotein, Unusual Pharmacokinetics +14

Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.

Eiichi Fuse, Hiromi Tanii, K Takai et al. · PubMed · 1999 · 73 citations

Alpha1-acid Glycoprotein, Altered Pharmacokinetics, Biochemistry +14

Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01

Noriaki Kurata, Takashi Kuwabara, Hiromi Tanii et al. · Cancer Chemotherapy and Pharmacology · 1999 · 23 citations

Physiologically-based Pharmacokinetic Modeling, Medicine, Receptor Tyrosine Kinase +4

Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urine

Noriaki Kurata, Tomoko Kuramitsu, Hiromi Tanii et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1998 · 14 citations

Preclinical Drug Evaluation, Medicine, Bioanalysis +12

Phase I and pharmacologic study of oral (E)-2′-deoxy-2′-(fluoromethylene) cytidine: on a daily × 5-day schedule

Noriyuki Masuda, Shunichi Negoro, Kouji Takeda et al. · Investigational New Drugs · 1998 · 11 citations

Medicinal Chemistry, Medicine, Pharmacotherapy +2